Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.